前FDA官员批评DOGE政策为灾难,阿斯利康达成AI合作
STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more
三位前美国食品药品监督管理局(FDA)局长批评特朗普政府主导的DOGE计划,称其导致3500名员工离职并削弱了机构知识,罗伯特·卡利夫称DOGE将成为美国历史上最大的灾难之一。此外,美国联邦政府将一项旨在限制从国际药房购买处方药的规定推迟90天生效,阿斯利康达成了一项AI合作。
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are greeting us as we prepare for another day on the road, which means we are as busy as ever hunting and gathering items of interest, as well as an acceptable cup of stimulation. We can be fussy, you know. So while we roam the streets, you can enjoy the latest menu of interesting items assembled below. Hope you have a grand day and do stay in touch — but only real people, please, no AI bots. …
Three former U.S. Food and Drug Administration chiefs lit into the Trump administration, criticizing the now former FDA officials who oversaw a massive staff exodus and saying they robbed the agency of institutional knowledge that will take years to restore, STAT reports. “DOGE will go down as one of the biggest disasters in American history,” said Robert Califf, who was FDA commissioner under Presidents Obama and Biden. The DOGE cuts of 3,500 workers preceded a larger staff exodus under the tumultuous leadership of former FDA Commissioner Marty Makary, who resigned in May.
The Trump administration is delaying by 90 days a federal rule that could prevent Americans from obtaining prescription drugs from licensed international pharmacies, STAT writes. The move follows growing criticism that the rule, which was initially slated to go into effect on Oct. 22, could drastically reduce the flow of medicines from Canada and other countries. In recent weeks, patient advocacy groups and dozens of congressional lawmakers urged the administration to rethink its approach. The administration is trying to crack down on illegal goods — particularly opioids — that it says enter the U.S. through low-value foreign shipments and for which shippers generally do not pay tariffs or submit data for tracking.
来源:STAT Pharma 医药频道 · statnews.com